The SQ tree SLIT-tablet is highly effective and well tolerated: Results from a randomized, double-blind, placebo-controlled phase III trial-Reference-Cited by-同舟云学术

The SQ tree SLIT-tablet is highly effective and well tolerated: Results from a randomized, double-blind, placebo-controlled phase III trial

Published:2019-03 Issue:3 Volume:143 Page:1058-1066.e6
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Biedermann Tilo,Kuna Piotr,Panzner Petr,Valovirta Erkka,Andersson Morgan,de Blay Frederic,Thrane Dorthe,Jacobsen Sanja Hald,Stage Brian Sonne,Winther Lone

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference39 articles.

1. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision;Brozek;J Allergy Clin Immunol,2017

2. Tree pollen allergens-an update from a molecular perspective;Asam;Allergy,2015

3. Geographic and temporal variations in pollen exposure across Europe;Smith;Allergy,2014

4. The principle of homologous groups in regulatory affairs of allergen products—a proposal;Lorenz;Int Arch Allergy Immunol,2008

5. Molecular, proteomic and immunological parameters of allergens provide inclusion criteria for new candidates within established grass and tree homologous groups;Heath;World Allergy Organ J,2015

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-dose interleukin-2 in birch pollen allergy: a phase-2 randomized double-blind placebo-controlled trial;2024-09-04

2. Focused allergic rhinitis practice parameter for Canada;Allergy, Asthma & Clinical Immunology;2024-08-08

3. Sublingual allergen immunotherapy prevents house dust mite inhalant type 2 immunity through dendritic cell-mediated induction of Foxp3+ regulatory T cells;Mucosal Immunology;2024-08

4. IL‐10‐modulated dendritic cells from birch pollen‐ and hazelnut‐allergic patients facilitate Treg‐mediated allergen‐specific and cross‐reactive tolerance;Allergy;2024-07-28

5. Consistent efficacy and safety of sublingual immunotherapy tablets across allergens and geographic regions;Allergy and Asthma Proceedings;2024-07-01